Merck, Simcere JV fallout

A high-profile China joint venture formed in 2011 between Simcere Pharmaceutical Group (Nanjing, China) and Merck & Co. Inc. (NYSE:MRK) appears to be coming to an end, with Simcere taking

Read the full 309 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE